A combination of a fixed dose of carboplatin plus paclitaxel and adriamycin in first line therapy for advanced ovarian cancer and suboptimal surgical cytoreduction. A phase I trial of the Spanish group for ovarian cancer research and treatment (GEICO)
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S239-239
- https://doi.org/10.1016/s0959-8049(99)81361-6
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: